Laser treatment under rigid bronchoscopy for malignant airway tumors: report of one case and review of literature

Q4 Medicine

肿瘤研究与临床 Pub Date : 2019-11-28 DOI:10.3760/CMA.J.ISSN.1006-9801.2019.11.015

Xiangzhen Meng, Jiwang Wang, Jiashu Li, Hong Zheng

引用次数: 0

Abstract

目的探讨经硬质支气管镜激光治疗主气道恶性肿瘤的安全性及有效性。方法回顾性分析连云港市第一人民医院收治的1例采用硬质支气管镜下激光介入治疗的主气道恶性肿瘤患者的临床资料，并复习相关文献。结果本例患者硬质支气管镜介入激光治疗术后呼吸困难症状明显改善，并发症少，恢复良好。结论经硬质支气管镜激光治疗主气道腔内恶性肿瘤，有助于疏通气道，即时缓解患者呼吸困难症状，并发症少，对于无手术机会的支气管恶性肿瘤患者可临时缓解病情。

查看原文本刊更多论文

硬质支气管镜下激光治疗气道恶性肿瘤1例报告及文献复习

Objective: To investigate the safety and effectiveness of laser treatment for primary airway malignant tumors through rigid bronchoscopy. Method: A retrospective analysis was conducted on the clinical data of a patient with primary airway malignant tumor treated with laser intervention under rigid bronchoscopy at Lianyungang First People's Hospital, and relevant literature was reviewed. The results showed that the patient had significantly improved respiratory distress symptoms, fewer complications, and a good recovery after the rigid bronchoscopy intervention laser treatment. Conclusion: Laser treatment of malignant tumors in the main airway cavity through rigid bronchoscopy can help to clear the airway, immediately alleviate respiratory difficulties in patients, with fewer complications, and temporarily alleviate the condition for patients with bronchial malignant tumors without surgical opportunities.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

肿瘤研究与临床 Medicine-Oncology

CiteScore

0.10

自引率

0.00%

发文量

7737

期刊介绍： "Cancer Research and Clinic" is a series of magazines of the Chinese Medical Association under the supervision of the National Health Commission and sponsored by the Chinese Medical Association. It mainly reflects scientific research results and academic trends in the field of malignant tumors. The main columns include monographs, guidelines and consensus, standards and norms, treatises, short treatises, survey reports, reviews, clinical pathology (case) discussions, case reports, etc. The readers are middle- and senior-level medical staff engaged in basic research and clinical work on malignant tumors.